News Headlines
Aurobindo Buys Dee Plant
SP Biotech park sees 82% land in Phase – I sold
Russia to ease registration norms for drug imports
SP Biotech Park to be expanded
Bharat Biotech to raise $ 20 mn via private placement
Neuland labs calls EGM for pref allotment
Matrix Labs firms up profit sharing pact with US firms
ICICI Knowledge park plans another expansion – Third Phase to be ready early next year
ICICI Knowledge park seeks lease term of 99 years
More withdrawals from WHO List; US scrutiny – Indian Pharma companies face testing time
AP keen to attract more FDIs in pharma, horticulture sectors
Dr. Reddy’s to pen global R&D pact by fiscal end
Drugs will be cheaper from April Next year
Merck outsources discovery research work from Indian CROs
KCP Biotech setting up colour extraction plant with IICT help
Alan Sheppard to head Dr Reddy's Europe generics business
Orchid identifies lifestyle drugs as its thrust area
HC clears Matrix Labs merger proposal
IFC set to invest $4 m in AP venture fund
ICRISAT bags two awards
Shriram group, Sembcorp may pick up stake in Ramky
Virtusa eyes healthcare, pharma sectors
ICICI Knowledge Park sets up life sciences incubator with DST funding
Singapore major sets up medical centre at H'bad, plans stem cell bank
Serum to launch combination vaccine
Bullish Burrill sets aside $100 mn for Asia push
DRL gets USFDA nod for Citalopram
Aurobindo gets USFDA nod
FDA nod for DRL’s anti-depressant
DRL gets USFDA nod for Citalopram
Biotech Cos Flock To Shapoorji Pallonji Park
ICICI park pioneers business-driven research
AP to hold first global biotech event BioAsia 2004 in Feb
India poised to benefit in pharma sector: E&Y
Growth Cohorts
Biotech Park set to enter 2nd phase
Hyderabad adds Genome Valley to its crown
India's first bio-tech park in Andhra
Ranbaxy plans Hyderabad facilities
Eyeing a share of the pie
Aktiva to have GMP facility at Biotech Park
Herbal garden opened
Biotech incubator to be operational soon
ICICI Knowledge Park to expand, invest Rs 7 crore
AP showcases Genome Valley at Bio-2003
AP showcases Genome Valley at Bio-2003
City emerging a biotech hub: Naidu
Nation's first agri-biotech park to come up in AP's Genome Valley
Genome Valley to pitch for investors at B'lore Bio 2003
Matrix Labs sets a turnover target of Rs.1000 crore by 2006
Post-IT, Naidu looks at Genome Valley
GVK Bio lines up Rs 100 cr investment plan
GVK Bio lines up Rs 100 cr investment plan
Biotech beckons